Cargando…

Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy

PURPOSE: Several recent studies have suggested improved clinical outcomes in diabetic men with prostate cancer who also use metformin. We explore whether metformin use is associated with improved outcomes specifically in men undergoing prostate brachytherapy. MATERIAL AND METHODS: 2,298 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taira, Al V., Merrick, Gregory S., Galbreath, Robert W., Morris, Mallory, Butler, Wayne M., Adamovich, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200187/ https://www.ncbi.nlm.nih.gov/pubmed/25337126 http://dx.doi.org/10.5114/jcb.2014.45757

Ejemplares similares

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
por: Merrick, Gregory S., et al.
Publicado: (2015)

Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials
por: Merrick, Gregory S., et al.
Publicado: (2017)

Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA
por: Merrick, Gregory S., et al.
Publicado: (2017)

Permanent prostate brachytherapy extracapsular radiation dose distributions: analysis of a multi-institutional database
por: Merrick, Gregory S., et al.
Publicado: (2013)

Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment
por: Taira, Al V., et al.
Publicado: (2013)

The impact of age on prostate cancer progression and quality of life in active surveillance patients
por: Merrick, Gregory S., et al.
Publicado: (2020)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting
por: Taira, A V, et al.
Publicado: (2009)

Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer
por: Breen, William, et al.
Publicado: (2018)

Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
por: Butler, Wayne M., et al.
Publicado: (2021)

Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS
por: Ishiyama, Hiromichi, et al.
Publicado: (2016)

CT-PLANNED transperineal prostate BIOPSY IN patients without a rectum
por: Merrick, Gregory S., et al.
Publicado: (2020)

Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy
por: Kawakami, Shogo, et al.
Publicado: (2017)

Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach
por: Wallace, T., et al.
Publicado: (2013)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Combination of Permanent Interstitial (125)I-Seed Brachytherapy and Surgery for the Treatment of Large Hepatocellular Carcinoma
por: Li, Xiaogang, et al.
Publicado: (2017)

cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer
por: Orio, Peter F, et al.
Publicado: (2009)

Edema‐induced changes in tumor cell surviving fraction and tumor control probability in [Formula: see text] permanent prostate brachytherapy implant patients
por: Kehwar, Than S., et al.
Publicado: (2013)

Effect of constipation on dosimetry after permanent seed brachytherapy for prostate cancer
por: Otón, L. Fernando, et al.
Publicado: (2015)

A comparative evaluation of loading times and exposures for permanent prostate brachytherapy
por: Bice, W. S., et al.
Publicado: (2002)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
por: Thormann, Maximilian, et al.
Publicado: (2022)

Comparison between preoperative and real-time intraoperative planning (125)I permanent prostate brachytherapy: long-term clinical biochemical outcome
por: Matzkin, Haim, et al.
Publicado: (2013)

Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’
por: Ahmed, Kamran A, et al.
Publicado: (2014)

Quality of life of men treated with brachytherapies for prostate cancer
por: Lev, Elise L, et al.
Publicado: (2004)

A simple technique for the generation of institution-specific nomograms for permanent prostate cancer brachytherapy
por: Lafata, Kyle J., et al.
Publicado: (2014)

A novel greedy heuristic‐based approach to intraoperative planning for permanent prostate brachytherapy
por: Liang, Bin, et al.
Publicado: (2015)

A comparison study on various low energy sources in interstitial prostate brachytherapy
por: Bakhshabadi, Mahdi, et al.
Publicado: (2016)

Influence of body mass index and periprostatic fat on rectal dosimetry in permanent seed prostate brachytherapy
por: Tiberi, David, et al.
Publicado: (2014)

Interstitial Brachytherapy for Orbital Sebaceous Carcinoma
por: Li, Feng, et al.
Publicado: (2021)

Single institution implementation of permanent (131)Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
por: Bar-Ad, Voichita, et al.
Publicado: (2019)

Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study
por: Kharouta, Michael, et al.
Publicado: (2021)

Postoperative interstitial brachytherapy in eyelid cancer: long term results and assessment of Cosmesis After Interstitial Brachytherapy scale
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2014)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy
por: Inada, Masahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6056b5kqbtv81co15uo5ubndhr